Vim is a company.
Vim has raised $26.0M across 2 funding rounds.
Key people at Vim.
Vim has raised $26.0M in total across 2 funding rounds.
Vim has raised $26.0M in total across 2 funding rounds.
Vim's investors include Battery Ventures, HC9 Ventures, Insight Partners, Mango Capital, Mayfield, Sequoia Capital Israel, Thylacine Capital.
Vim is a U.S.-based healthcare technology company that builds a digital platform aligning incentives between health plans (payers) and care providers to enable value-based care decisions.[1][2] Its platform promotes affordable, convenient, high-quality care by helping doctors select optimal providers, guiding patients to the right care via online booking, and leveraging collective intelligence from healthcare data and human expertise.[1] Vim serves health plans and providers, solving collaboration challenges in value-based care, with estimated annual revenue of $10-50 million, over $95 million in total funding (including a $24 million Series B in 2019 led by Optum Ventures), and strong growth in the expanding healthcare IT market projected to reach $400 billion by 2027.[1][2]
The company demonstrates robust financials with improving EBITDA margins, consistent cash flows, and strategic investments from players like Sequoia Capital, Walgreens Boots Alliance, and Anthem, positioning it for market expansion and product acceleration.[1][2]
Vim emerged to address persistent friction between health plans and providers in delivering value-based care, where misaligned incentives hinder affordable, high-quality outcomes.[1] Founded prior to its 2019 Series B (exact year not specified in available data), the company quickly gained traction through proven results with clients, as noted by early strategic partner Richard Lungen of Leverage Health Solutions, who helped structure its go-to-market approach.[1] A pivotal moment came with the $24 million Series B on September 9, 2019, led by Optum Ventures alongside a national health insurer, Great Point Ventures, Sequoia Capital, and Leverage Health, validating its model and fueling U.S. market expansion, hiring, and product development.[1] This funding built on prior rounds, culminating in over $95 million total, reflecting confidence from strategic healthcare investors.[2]
(Note: Search results distinguish this Vim from unrelated entities like a training analytics app [3] or wealth management firm [4].)
Vim rides the shift to value-based care, where payers and providers must collaborate amid rising healthcare costs and demands for data-driven efficiency.[1][2] Timing aligns with healthcare IT's explosive growth—$270 billion in 2024 to $400 billion by 2027—fueled by EHR adoption, telehealth, and analytics, making Vim's payer-provider integration timely for navigating fragmented U.S. systems.[2] Market forces like regulatory pushes for outcomes over volume and investor interest in digital health (e.g., Optum's focus on accessible care) favor Vim, as its platform reduces friction and influences ecosystem-wide adoption of intelligent routing and booking.[1] By enabling better patient-provider matches, Vim contributes to a more navigable health system, amplifying trends in AI-enhanced care coordination.[1][2]
Vim's trajectory points to accelerated U.S. expansion, deepened product AI/data capabilities, and potential profitability scaling, bolstered by its funding war chest and partnerships amid healthcare IT's boom.[1][2] Trends like rising value-based care mandates and telehealth integration will propel growth, though financial pressures (e.g., 1.006% default probability noted in late 2025) warrant monitoring.[2] Its influence may evolve from niche collaborator to broader infrastructure leader, redefining payer-provider dynamics and echoing its Series B promise of transformative care access.[1]
Key people at Vim.
Vim has raised $26.0M across 2 funding rounds. Most recently, it raised $24.0M Series B in September 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2019 | $24.0M Series B | Battery Ventures, HC9 Ventures, Insight Partners, Mango Capital, Mayfield, Sequoia Capital Israel, Thylacine Capital | |
| Dec 1, 2014 | $2.0M Seed | Battery Ventures, Insight Partners, Mango Capital, Mayfield, Sequoia Capital Israel, Thylacine Capital |
